Skip to main content

DAWNZERA

Generic: donidalorsen

Verified·Oct 26, 2026
NDC
71860-103
RxCUI
2724447
Route
SUBCUTANEOUS
ICD-10 indication
F20.9

Affordability Check

How much will you actually pay for DAWNZERA?

In 30 seconds, see every legitimate way to afford DAWNZERA — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About DAWNZERA

What is this medication? Silenor is a prescription medication primarily used to treat insomnia in adults, specifically focusing on sleep maintenance issues. It is designed for patients who have trouble staying asleep once they have gone to bed, rather than those who only have trouble falling asleep initially. This medication contains a low dose of the active ingredient doxepin, which is a member of the tricyclic antidepressant family but is used at these specific levels for its sedating properties. The drug functions by acting as a selective histamine H1 receptor antagonist in the brain. By blocking histamine, which is a chemical that promotes alertness and wakefulness, the medication helps the body maintain a state of sleep throughout the night. It is typically taken once daily within thirty minutes of bedtime, and it is important to follow a doctor's instructions to avoid taking it too late in the night, which helps minimize potential side effects or morning grogginess.

Copay & patient assistance

  • Patient Copay Amount: As little as $0 out-of-pocket
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Patients must have commercial insurance coverage. The program is not available to individuals who use any state or federal government-funded healthcare program to cover a portion of medication costs, including Medicare, Medicaid, TRICARE, Department of Defense, or Veterans Administration.
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Medicare Part D coverage

How DAWNZERA appears across Medicare Part D plan formularies nationally. Source: CMS monthly Prescription Drug Plan file (2026-08-31).

Covered by plans

1%

35 of 5,499 plans

Most common tier

Tier 5

On 56% of covering formularies

Prior authorization required

100%

of covering formularies

TierFormularies on this tierShare
Tier 1 (preferred generic)1
11%
Tier 2 (generic)1
11%
Tier 4 (non-preferred brand)2
22%
Tier 5 (specialty)5
56%

Step therapy: 0% of formularies

Quantity limits: 78% of formularies

Coverage breadth: 9 of 65 formularies

How to read this:plans on the same formulary share tier + PA rules. Your specific plan's copay depends on (a) the tier above, (b) your plan's cost-share for that tier, (c) whether you're in the initial coverage phase or past the 2026 $2,000 out-of-pocket cap. For your exact plan, check its Summary of Benefits or log in to your Medicare.gov account. Copay cards don't apply to Medicare (federal law).

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

Yes——

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.

Rare-disease navigation (specialists, trials, patient communities)

DAWNZERA treats a rare condition. For in-depth disease pages on our sister site:

UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.